Midazolam 5 Mg Injection Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV), Intramuscular (IM), and Intranasal Injection

Available Strengths: 1 mg/mL, 5 mg/mL

Reference Brands: Versed(US);

Category: Critical Care

Midazolam is a fast-acting benzodiazepine for sedation, seizures, and anesthesia, available in 1 mg/mL and 5 mg/mL injections and 2 mg/mL oral syrup. Brands include Versed, Buccolam, and Midazolam B. Braun. It is widely sourced via pharma B2B platforms for hospitals, ICUs, and emergency medical services. Midazolam 5 mg Injection is available in Intravenous (IV), Intramuscular (IM), and Intranasal Injection and strengths such as 1 mg/mL, 5 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Midazolam 5 mg Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Midazolam 5 mg Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Midazolam is a short-acting benzodiazepine used for procedural sedation, anesthesia induction, seizures, and ICU sedation. Available in injectable forms (1 mg/mL, 5 mg/mL), oral syrup (2 mg/mL), and buccal/rectal solutions, it is supplied in ampoules, vials, and pre-filled syringes. US brands include Versed and generics from Pfizer and Fresenius, while the EU markets Buccolam (buccal), Midazolam Accord, and B. Braun formulations. Midazolam’s rapid onset and versatility make it essential in hospitals, ambulatory centers, and emergency care. Pharma B2B platforms regularly supply Midazolam to healthcare institutions through streamlined procurement channels for anesthesia and critical care needs.